Atlas FDA

Spectra Optia Apheresis System, REF: 61000, Caridian BCT, Lakewood, CO 80215. A blood component separator used for thera

FDA device recall Z-0191-2012 · posted 2011-11-16 · Terminated

Recall details

Recalling firm
Caridian BCT, Incorporated
Reason for recall
Possible higher than expected platelet loss following therapeutic plasma exchange or plasmapheresis.
Action taken
CaridianBCT sent a "Safety Alert" letter dated September 2011, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The firm will be sending a recall letter to consignees in November 2011, stating they are voluntarily recalling the software and will provide an upgrade once the software has been approved. If you have any further questions please contact your CaridianBCT Representative, the CaridianBCT Support Center at 1-877-3-FYU-BCT ( US Toll free 1-877-299-4228 ) or (303) 231-HELP ) ( 1 (303) 231-4357, or your local CaridianBCT Customer Service office.
Root cause
Software design
Status
Terminated
Product code
LKN
Quantity affected
852 units (US: 333; Foreign: 519)
Distribution
Worldwide Distribution -- USA ( nationwide ) and the countries of Australia, Belgium, Canada, Chile, China, Colombia, Hong Kong, India, Japan, Malaysia, Mexico, Pakistan, Republic of Korea, Saudi Arab
Date initiated
2011-09-21
Date posted
2011-11-16
Date terminated
2013-02-01
Location
Lakewood, CO

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.

Related 510(k) clearances

RecordFirmDate
SPECTRA OPTIA R APHERESIS SYSTEM (K103090)Caridianbct, Inc..2010-11-19
SPECTRA OPTIA APHERESIS SYSTEM, SPECTRA OPTIA EXCHANGE SET, MODEL 61000, 10200 (K071079)Gambro Bct, Inc.2007-08-02